#None #Bausch Health #YUN #Probiotherapy

Strategic Expansion of Bausch Health and YUN

Bausch Health Companies Inc., a global leader in pharmaceuticals, has recently announced its partnership with Belgian innovator YUN to expand its market reach into Mexico and additional European, Middle Eastern, and African (EMEA) regions. This strategic alliance aims to enhance accessibility to science-led skincare solutions that emphasize the importance of microbiome health.

Expanding Access and Product Lines

The collaboration, which builds on their previous success in Poland with YUN's probiotic-based skincare products, represents not only an extension in product offerings but also a geographical expansion to new markets. Recently, YUN's skincare solutions targeting eczema and acne-prone skin successfully launched in the Czech Republic, Slovakia, Ukraine, and Bulgaria. Mexico marks the latest addition to Bausch Health's growing dermatology portfolio, set to diversify offerings in the Latin American market.

Fernando Zarate, Vice President for Latin America at Bausch Health, highlighted how this launch in Mexico is integral in addressing evolving dermatological needs. “This reflects our focus on innovating dermatology offerings, ensuring that patients have access to effective and safe skincare solutions,” he stated.

The Science Behind YUN’s Products

YUN has developed a proprietary technology known as YUN Probiotherapy™, which utilizes live probiotics in its skincare formulations. This innovative approach to everyday skincare strives to maintain a balance within the skin's natural ecosystem. The products not only aim to treat skin issues but also respect and support the body’s natural balance, making YUN stand out in the competitive skincare landscape.

Tom Verlinden, CEO and Founder of YUN, expressed pride in advancing their collaboration with Bausch Health, stating, “This expansion allows us to bring microbiome-centric solutions, guided by scientific research, to a wider audience.” This mission of creating effective, natural solutions underlines the partnership’s commitment to improving public health and skincare.

Future Growth in EMEA

The ambition does not stop with Mexico. Plans are already underway for a rollout in Kazakhstan, scheduled for October 2026. The expansion is part of a larger strategy to enhance access to microbiome-friendly skincare throughout selected EMEA markets. Cees Heiman, Senior VP at Bausch Health, acknowledged the importance of EMEA as a key market while noting the strong potential for YUN's unique approach to skincare in these regions.

The partnership between Bausch Health and YUN embodies a forward-thinking approach in a therapeutic space that increasingly emphasizes the science behind skincare. As they introduce more innovative products, both companies are committed to ensuring they meet the demands of both consumers and medical professionals alike.

Conclusion

As Bausch Health and YUN embark on this exciting journey into new territories, the emphasis on microbiome health in skincare solutions promises to foster a positive impact across diverse demographics. With a shared vision of enhancing healthcare outcomes, this expansion serves as a significant step in making advanced skincare accessible to all, marrying elegance with evidence-based care. With keen anticipation, the industry will watch as this partnership unfolds, potentially setting new standards in skincare and overall consumer health.